{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:40:11Z","timestamp":1765280411739,"version":"3.37.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1124\/molpharm.123.000787","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T22:40:12Z","timestamp":1703198412000},"page":"224-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibition of Cardiac Kv4.3\/KChIP2 Channels by Sulfonylurea Drug Gliquidone"],"prefix":"10.1016","volume":"105","author":[{"given":"Chenxia","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-9998","authenticated-orcid":false,"given":"KeWei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.123.000787_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fphys.2020.00583","article-title":"KCNQs: ligand- and voltage-gated potassium channels","volume":"11","author":"Abbott","year":"2020","journal-title":"Front Physiol"},{"issue":"Suppl 6","key":"10.1124\/molpharm.123.000787_bib2","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jelectrocard.2007.05.021","article-title":"Impact of ancillary subunits on ventricular repolarization","volume":"40","author":"Abbott","year":"2007","journal-title":"J Electrocardiol"},{"key":"10.1124\/molpharm.123.000787_bib3","doi-asserted-by":"crossref","first-page":"aac5464","DOI":"10.1126\/science.aac5464","article-title":"Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist","volume":"350","author":"Ahuja","year":"2015","journal-title":"Science"},{"key":"10.1124\/molpharm.123.000787_bib4","doi-asserted-by":"crossref","first-page":"H602","DOI":"10.1152\/ajpheart.00673.2003","article-title":"Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito","volume":"286","author":"Akar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/molpharm.123.000787_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1253\/circj.CJ-12-0284","article-title":"Genetic, molecular and cellular mechanisms underlying the J wave syndromes","volume":"76","author":"Antzelevitch","year":"2012","journal-title":"Circ J"},{"key":"10.1124\/molpharm.123.000787_bib6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1113\/jphysiol.2007.139279","article-title":"Modification of K+ channel-drug interactions by ancillary subunits","volume":"586","author":"Bett","year":"2008","journal-title":"J Physiol"},{"key":"10.1124\/molpharm.123.000787_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1152\/physrev.00039.2003","article-title":"Structure and function of Kv4-family transient potassium channels","volume":"84","author":"Birnbaum","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1124\/molpharm.123.000787_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","article-title":"Present status of Brugada syndrome: JACC state-of-the-art review","volume":"72","author":"Brugada","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/molpharm.123.000787_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cardiores.2004.07.022","article-title":"Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations","volume":"64","author":"Caballero","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/molpharm.123.000787_bib10","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.jacc.2018.08.2199","article-title":"Brugada syndrome: in search of a cause","volume":"72","author":"Corrado","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/molpharm.123.000787_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.106.630905","article-title":"AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat","volume":"114","author":"de Haan","year":"2006","journal-title":"Circulation"},{"key":"10.1124\/molpharm.123.000787_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/19336950.2022.2053420","article-title":"Effects of JZTX-V on the wild type Kv4.3 expressed in HEK293T and molecular determinants in the voltage-sensing domains of Kv4.3 interacting with JZTX-V","volume":"16","author":"Dehong","year":"2022","journal-title":"Channels (Austin)"},{"key":"10.1124\/molpharm.123.000787_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/mol.109.055657","article-title":"S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3","volume":"76","author":"DeSimone","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.123.000787_bib14","doi-asserted-by":"crossref","first-page":"e0242747","DOI":"10.1371\/journal.pone.0242747","article-title":"Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes","volume":"15","author":"Di Diego","year":"2020","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.123.000787_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.RES.79.4.659","article-title":"Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current","volume":"79","author":"Dixon","year":"1996","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.123.000787_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/humu.22058","article-title":"Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death","volume":"33","author":"Giudicessi","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1124\/molpharm.123.000787_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2011.02.021","article-title":"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome","volume":"8","author":"Giudicessi","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1124\/molpharm.123.000787_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cvr\/cvn205","article-title":"Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1)","volume":"80","author":"G\u00f3mez","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1124\/molpharm.123.000787_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bjp.0705281","article-title":"Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells","volume":"139","author":"Hatano","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.123.000787_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(01)01252-3","article-title":"Effect of insulinotropic agent nateglinide on Kv and Ca(2+) channels in pancreatic beta-cell","volume":"427","author":"Hu","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 8","key":"10.1124\/molpharm.123.000787_bib21","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.hrthm.2009.02.009","article-title":"Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome","volume":"6","author":"Kaufman","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1124\/molpharm.123.000787_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41586-021-03935-z","article-title":"Structural basis of gating modulation of Kv4 channel complexes","volume":"599","author":"Kise","year":"2021","journal-title":"Nature"},{"key":"10.1124\/molpharm.123.000787_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000508033","article-title":"A novel gain-of-function KCND3 variant associated with Brugada syndrome","volume":"145","author":"Li","year":"2020","journal-title":"Cardiology"},{"key":"10.1124\/molpharm.123.000787_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2015.05.036","article-title":"The effect of gliquidone on KATP channels in pancreatic \u03b2-cells, cardiomyocytes, and vascular smooth muscle cells","volume":"109","author":"Liu","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1124\/molpharm.123.000787_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41422-021-00608-4","article-title":"Structural basis for the gating modulation of Kv4.3 by auxiliary subunits","volume":"32","author":"Ma","year":"2022","journal-title":"Cell Res"},{"key":"10.1124\/molpharm.123.000787_bib27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.hrthm.2013.03.011","article-title":"Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome","volume":"10","author":"Minoura","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1124\/molpharm.123.000787_bib28","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1080\/07391102.2022.2106514","article-title":"Insight on the interaction between the scorpion toxin blocker Discrepin on potassium voltage-gated channel Kv4.3 by molecular dynamics simulations","volume":"41","author":"Montero-Dom\u00ednguez","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/molpharm.123.000787_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI82670","article-title":"Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease","volume":"126","author":"Naranjo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.123.000787_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2009.07.013","article-title":"Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation","volume":"48","author":"Niwa","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/molpharm.123.000787_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bjp.0702904","article-title":"The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes","volume":"128","author":"Schaffer","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/molpharm.123.000787_bib34","first-page":"S8","article-title":"Cell-to-cell electrical interactions during early and late repolarization","volume":"17","author":"Spitzer","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1124\/molpharm.123.000787_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.hrthm.2009.10.029","article-title":"Cardiac I(to), KCNE2, and Brugada syndrome: promiscuous subunit interactions, or what happens in HEK cells stays in HEK cells?","volume":"7","author":"Tomaselli","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1124\/molpharm.123.000787_bib36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/aps.2015.83","article-title":"Effects of neferine on Kv4.3 channels expressed in HEK293 cells and ex vivo electrophysiology of rabbit hearts","volume":"36","author":"Wang","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/molpharm.123.000787_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nn1822","article-title":"Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP subunits","volume":"10","author":"Wang","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1124\/molpharm.123.000787_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3565(25)24304-X","article-title":"Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes","volume":"272","author":"Wang","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.123.000787_bib39","doi-asserted-by":"crossref","first-page":"e57864","DOI":"10.1371\/journal.pone.0057864","article-title":"Properties and molecular determinants of the natural flavone acacetin for blocking hKv4.3 channels","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.123.000787_bib40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cell.2018.12.018","article-title":"Structural basis of Nav1.7 inhibition by a gating-modifier spider toxin","volume":"176","author":"Xu","year":"2019","journal-title":"Cell"},{"key":"10.1124\/molpharm.123.000787_bib41","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/molpharm.123.000787_bib42","doi-asserted-by":"crossref","first-page":"e003238","DOI":"10.1161\/CIRCGEN.120.003238","article-title":"KCND3-encoded Kv4.3 gain-of-function-associated J-wave syndromes","volume":"15","author":"Ye","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"10.1124\/molpharm.123.000787_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3892\/ijmm.2015.2223","article-title":"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function","volume":"36","author":"You","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1124\/molpharm.123.000787_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fnmol.2018.00253","article-title":"A-type KV channels in dorsal root ganglion neurons: diversity, function, and dysfunction","volume":"11","author":"Zemel","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/molpharm.123.000787_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2019.03.029","article-title":"Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells","volume":"853","author":"Zhang","year":"2019","journal-title":"Eur J Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24001007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24001007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.123.000787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:29:39Z","timestamp":1739957379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24001007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0026895X24001007"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.123.000787","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Cardiac Kv4.3\/KChIP2 Channels by Sulfonylurea Drug Gliquidone","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.123.000787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}